Level Biotechnology Balance Sheet Health
Financial Health criteria checks 6/6
Level Biotechnology has a total shareholder equity of NT$549.5M and total debt of NT$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are NT$822.7M and NT$273.2M respectively. Level Biotechnology's EBIT is NT$67.6M making its interest coverage ratio -13.9. It has cash and short-term investments of NT$467.4M.
Key information
0%
Debt to equity ratio
NT$0
Debt
| Interest coverage ratio | -13.9x |
| Cash | NT$467.41m |
| Equity | NT$549.47m |
| Total liabilities | NT$273.20m |
| Total assets | NT$822.67m |
Recent financial health updates
No updates
Recent updates
Some Investors May Be Worried About Level Biotechnology's (GTSM:3118) Returns On Capital
Apr 27
Calculating The Fair Value Of Level Biotechnology Inc. (GTSM:3118)
Mar 16Here's What You Should Know About Level Biotechnology Inc.'s (GTSM:3118) 3.6% Dividend Yield
Feb 14Does Level Biotechnology's (GTSM:3118) Returns On Capital Reflect Well On The Business?
Jan 24
Level Biotechnology Inc.'s (GTSM:3118) Stock Has Shown A Decent Performance: Have Financials A Role To Play?
Jan 03Calculating The Intrinsic Value Of Level Biotechnology Inc. (GTSM:3118)
Dec 16Here's Why We Think Level Biotechnology's (GTSM:3118) Statutory Earnings Might Be Conservative
Nov 28Financial Position Analysis
Short Term Liabilities: 3118's short term assets (NT$680.5M) exceed its short term liabilities (NT$252.8M).
Long Term Liabilities: 3118's short term assets (NT$680.5M) exceed its long term liabilities (NT$20.4M).
Debt to Equity History and Analysis
Debt Level: 3118 is debt free.
Reducing Debt: 3118 has not had any debt for past 5 years.
Debt Coverage: 3118 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 3118 has no debt, therefore coverage of interest payments is not a concern.